Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

MammaPrint

Known as: Agendia 
MammaPrint is a diagnostic test to assess the risk that a breast tumor will metastasize to other parts of the body. This helps physicians determine… Expand
Wikipedia

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
INTRODUCTION: Majority of the approximately 40,610 deaths from metastatic breast cancer in the US each year occur in women with… Expand
2017
2017
Genomic aberrations and gene expression-defined subtypes in the large METABRIC patient cohort have been used to stratify and… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • table 2
2015
2015
11017 Background: The Objective of our study was to investigate the concordance of patient results from a single university… Expand
Review
2014
Review
2014
GENETICS NOMENCLATURE UPDATE The Human Genome Variation Society nomenclature is used to report information on variants found in… Expand
  • table 2
  • table 1
  • table 3
  • table 4
  • table 5
2014
2014
SUMMARY OBJECTIVE: We show our experience with test of 70 genes (Mammaprint ® ), in evaluation and the treatment patients with… Expand
2011
2011
The objective of this work was information of genetic characteristics of tumor, determined by methods such as mamma print… Expand
Review
2009
Review
2009
Purpose: The level of estrogen receptor (ER), progesterone receptor (PR), and HER2 aids in the determination of prognosis and… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 3
2009
2009
Risk assessment for breast cancer patients differs substantially among treatment guidelines. The NCCN, St.Gallen, Adjuvant!Online… Expand
Review
2008
Review
2008
The explosion in knowledge about the molecular and cellular biology of cancer has led to the identification of many molecules or… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 1
  • table 2